🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II study of the combination of All-Trans Retinonic Acid (AT...
Status
Recruiting
Location
University of Pennsylvania
Start Date
2022-11-16
Trial ID
NCT05345002
Treatments Being Tested
The goal of this clinical trial is to assess safety of pan-metastases direc...
Status
Recruiting
Location
Centre Léon Bérard
Start Date
2024-07-11
Trial ID
NCT06439888
Treatments Being Tested
This research is studying how safe and effective all-trans retinoic acid (A...
Status
Completed
Location
Massachusetts General Hospital Cancer Center
Start Date
2019-08-05
Trial ID
NCT03999684
Treatments Being Tested
The project was undertaking by Qilu Hospital of Shandong University in Chin...
Status
Withdrawn
Location
Qilu Hospital, Shandong University
Start Date
2013-02
Trial ID
NCT01882127
Treatments Being Tested
This is a Phase IB/II trial that will investigate the safety, tolerability ...
Status
Recruiting
Location
Houston Methodist Neal Cancer Center
Start Date
2024-07-29
Trial ID
NCT06536413
This is an open label, prospective, single institution dose-escalation stud...
Status
Completed
Location
University of Pittsburgh Cancer Institute - Hillman Cancer Center
Start Date
2011-04
Trial ID
NCT00892190
Treatments Being Tested
This is a prospective, open-label, randomized, cross-over, pilot study of r...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2018-08-20
Trial ID
NCT03572387
Treatments Being Tested
The purpose of this study is to test the safety and efficacy of the study d...
Status
Terminated
Location
John Theurer Cancer Center
Start Date
2022-05-02
Trial ID
NCT04700176
Treatments Being Tested
The trial is open to all patients with a diagnosis of acute promyelocytic l...
Status
Recruiting
Location
Hôpital Universitaire des Enfants Reine Fabiola (Huderf)
Start Date
2019-10-09
Trial ID
NCT04793919
Treatments Being Tested
An open-label, multicenter study to compare the efficacy and safety of ATRA...
Status
Unknown
Location
Peking University Institute of Hematology
Start Date
2020-11
Trial ID
NCT04618328
Treatments Being Tested